Novel therapeutic targets for ARID1A mutant ovarian clear cell carcinoma (OCCC)

被引：0
|
作者：
Miller, R. E. [1 ]
Bajrami, I. [1 ]
Brough, R. [1 ]
Konde, A. [1 ]
Campbell, J. [1 ]
Rafiq, R. [1 ]
Ashworth, A. [1 ]
Lord, C. J. [1 ]
机构：
[1] Inst Canc Res, London SW3 6JB, England
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70444-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
318
引用
收藏
页码：103 / 104
页数：2
相关论文
共 50 条
  • [31] SMARCA4 loss irrelevant for ARID1A mutated ovarian clear cell carcinoma: A case report
    Wagner, Samantha Kay
    Moon, Ashley S.
    Howitt, Brooke E.
    Renz, Malte
    GYNECOLOGIC ONCOLOGY REPORTS, 2023, 50
  • [32] Molecular profiling reveals novel therapeutic targets and clonal evolution in ovarian clear cell carcinoma
    Chao, Angel
    Huang, Chen-Yang
    Yu, Willie
    Lin, Chiao-Yun
    Lin, Hao
    Chao, An-Shine
    Lin, Cheng-Tao
    Chou, Hung-Hsueh
    Huang, Kuang-Gen
    Huang, Huei-Jean
    Chang, Ting-Chang
    Rozen, Steven G.
    Wu, Ren-Chin
    Lai, Chyong-Huey
    BMC CANCER, 2024, 24 (01)
  • [33] Efficacy of gemcitabine (gem) based therapy in ovarian clear cell carcinoma (OCCC)
    Loh, J.
    Ngoi, N. Y. L.
    Blanc-Durand, F.
    Ang, S. Y. R.
    Elias, E.
    Lai, A.
    Lim, D.
    Lim, Y. W.
    Lim, S. E.
    Low, J.
    Ng, J.
    Sundararajan, V.
    Thian, Y. L.
    Tong, P.
    Wijaya, S.
    Tan, D. S.
    ANNALS OF ONCOLOGY, 2023, 34 : S532 - S533
  • [34] ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
    Katrien Berns
    Joseph J. Caumanns
    E. Marielle Hijmans
    Annemiek M. C. Gennissen
    Tesa M. Severson
    Bastiaan Evers
    G. Bea A. Wisman
    Gert Jan Meersma
    Cor Lieftink
    Roderick L. Beijersbergen
    Hiroaki Itamochi
    Ate G. J. van der Zee
    Steven de Jong
    René Bernards
    Oncogene, 2018, 37 : 4611 - 4625
  • [35] ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
    Berns, Katrien
    Caumanns, Joseph J.
    Hijmans, E. Marielle
    Gennissen, Annemiek M. C.
    Severson, Tesa M.
    Evers, Bastiaan
    Wisman, G. Bea A.
    Meersma, Gert Jan
    Lieftink, Cor
    Beijersbergen, Roderick L.
    Itamochi, Hiroaki
    van der Zee, Ate G. J.
    de Jong, Steven
    Bernards, Rene
    ONCOGENE, 2018, 37 (33) : 4611 - 4625
  • [36] Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma
    Katagiri, Atsuko
    Nakayama, Kentaro
    Rahman, Mohammed Tanjimur
    Rahman, Munmun
    Katagiri, Hiroshi
    Nakayama, Naomi
    Ishikawa, Masako
    Ishibashi, Tomoka
    Iida, Kouji
    Kobayashi, Hiroshi
    Otsuki, Yoshiro
    Nakayama, Satoru
    Miyazaki, Kohji
    MODERN PATHOLOGY, 2012, 25 (02) : 282 - 288
  • [37] Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
    Yano, Mitsutake
    Katoh, Tomomi
    Miyazawa, Mariko
    Miyazawa, Masaki
    Ogane, Naoki
    Miwa, Maiko
    Hasegawa, Kosei
    Narahara, Hisashi
    Yasuda, Masanori
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [38] Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
    Mitsutake Yano
    Tomomi Katoh
    Mariko Miyazawa
    Masaki Miyazawa
    Naoki Ogane
    Maiko Miwa
    Kosei Hasegawa
    Hisashi Narahara
    Masanori Yasuda
    Scientific Reports, 9
  • [39] Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
    Yano, Mitsutake
    Katoh, Tomomi
    Miyazawa, Mariko
    Miyazawa, Masaki
    Ogane, Naoki
    Miwa, Maiko
    Hasegawa, Kosei
    Narahara, Hisashi
    Yasuda, Masanori
    MODERN PATHOLOGY, 2019, 32
  • [40] Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
    Yano, Mitsutake
    Katoh, Tomomi
    Miyazawa, Mariko
    Miyazawa, Masaki
    Ogane, Naoki
    Miwa, Maiko
    Hasegawa, Kosei
    Narahara, Hisashi
    Yasuda, Masanori
    LABORATORY INVESTIGATION, 2019, 99
12345